The inventive formulation can be used in the treatment of infections caused by bacteria, fungi and membrane viruses.
The method may be used to inactivate both lipid enveloped and non-lipid-enveloped viruses.
The present invention provides a method of inactivating lipid-enveloped virus in a solution of therapeutic protein.
The inhibitory action is applicable to enveloped viruses which express as sores at dermal surfaces in human.
A new method of inactivating enveloped viruses and preparations useful in accomplishing this inactivation are disclosed.
The HIV virus fusion inhibitor peptides can be used to produce compositions to inhibit infection of varied enveloped viruses.
The microbubbles and/or liposomes attract virus particles including envelope viruses.
Many viruses ("envelope viruses") are housed in lipid vesicles, but so are the neurotransmitters in our brains.
The instant invention describes novel methods for treating viral infections, in particular infections caused by high mannose enveloped viruses, for example hepatitis C virus (HCV).
The invention relates to the use of valproic acid or the salts or solvates thereof for the treatment of diseases caused by enveloped viruses, such as, for example, West Nile fever virus or Usutu virus.
Envelope viruses (e.g. Newcastle disease virus (NDV)) are formulated for storage at moderately cold temperatures (e.g. -20 °C).
The present invention provides methods for purifying Von Willebrand factor (VWF) for increased removal of non-lipid enveloped viruses.
In preferred examples, the field includes methods of inactivation of infectious agents that do not adversely affect the immunogenicity of the enveloped virus-based VLPs.
Enveloped virus-based virus-like particles (VLPs) that are free of infectious agents and substantially as immunogenic as corresponding VLPs prior to inactivation of infectious agents are described.
Over the years, a vast array of information concerning the interactions of viruses with their hosts has been collected.
In addition, virus inactivation and virus removal steps which are part of the manufacturing process, are considered effective for enveloped viruses such as HIV, HCV, HBV, and for the non-enveloped Hepatitis A virus (HAV).
The compositions of the invention can be used to decontaminate skin and environmental surfaces that are contacted with microorganisms such as envelope viruses.
Exosomes, like many viruses (i.e. enveloped viruses), are enclosed in a membrane, and are within the 50-100 nano-meter size range that viruses are (20-400 nm).
Exosomes, like many viruses (i.e. enveloped viruses) are enclosed in a membrane, and are within the 50-100 nanometer size range that viruses are (20-400 nm).
In vitro studies demonstrate that docosanol-treated cells resist infection by lipid-enveloped viruses such as HSV-1.
In vitro studies demonstrate that docosanol-treated cells resist infection by lipid-enveloped viruses such as HSV-1.
Requêtes fréquentes français :1-200, -1k, -2k, -3k, -4k, -5k, -7k, -10k, -20k, -40k, -100k, -200k, -500k, -1000k,
Requêtes fréquentes anglais :1-200, -1k, -2k, -3k, -4k, -5k, -7k, -10k, -20k, -40k, -100k, -200k, -500k, -1000k,
Traduction Translation Traducción Übersetzung Tradução Traduzione Traducere Vertaling Tłumaczenie Mετάφραση Oversættelse Översättning Käännös Aistriúchán Traduzzjoni Prevajanje Vertimas Tõlge Preklad Fordítás Tulkojumi Превод Překlad Prijevod 翻訳 번역 翻译 Перевод